FI884879A - Terapeutiskt anvaendbara heterocykliska foereningar. - Google Patents

Terapeutiskt anvaendbara heterocykliska foereningar. Download PDF

Info

Publication number
FI884879A
FI884879A FI884879A FI884879A FI884879A FI 884879 A FI884879 A FI 884879A FI 884879 A FI884879 A FI 884879A FI 884879 A FI884879 A FI 884879A FI 884879 A FI884879 A FI 884879A
Authority
FI
Finland
Prior art keywords
aryl
alkyl
group
benzyl
independently selected
Prior art date
Application number
FI884879A
Other languages
English (en)
Finnish (fi)
Other versions
FI884879A0 (fi
Inventor
Alan Duncan Robertson
Graeme Richard Martin
Janet Susan Buckingham
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of FI884879A0 publication Critical patent/FI884879A0/fi
Publication of FI884879A publication Critical patent/FI884879A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/06Antimigraine agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C07D209/16Tryptamines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fats And Perfumes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Indole Compounds (AREA)
FI884879A 1987-10-23 1988-10-21 Terapeutiskt anvaendbara heterocykliska foereningar. FI884879A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878724912A GB8724912D0 (en) 1987-10-23 1987-10-23 Indole derivatives

Publications (2)

Publication Number Publication Date
FI884879A0 FI884879A0 (fi) 1988-10-21
FI884879A true FI884879A (fi) 1989-04-24

Family

ID=10625806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI884879A FI884879A (fi) 1987-10-23 1988-10-21 Terapeutiskt anvaendbara heterocykliska foereningar.

Country Status (18)

Country Link
EP (1) EP0313397B1 (fr)
JP (1) JP2501631B2 (fr)
CN (1) CN1035113A (fr)
AT (1) ATE90089T1 (fr)
AU (1) AU604165B2 (fr)
DD (1) DD283140A5 (fr)
DE (1) DE3881472T2 (fr)
DK (1) DK586588A (fr)
ES (1) ES2054825T3 (fr)
FI (1) FI884879A (fr)
GB (1) GB8724912D0 (fr)
HU (1) HU202230B (fr)
IL (1) IL88122A0 (fr)
MC (1) MC1983A1 (fr)
NZ (1) NZ226671A (fr)
PL (1) PL158305B1 (fr)
PT (1) PT88829B (fr)
ZA (1) ZA887900B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT95899A (pt) * 1989-11-17 1991-09-13 Glaxo Group Ltd Processo para a preparacao de derivados indole
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
NZ238424A (en) * 1990-06-07 1993-12-23 Wellcome Found 3,5-substituted indole derivatives; medicaments and preparatory processes.
EP0494774A1 (fr) * 1991-01-11 1992-07-15 MERCK SHARP & DOHME LTD. Composés hétéroaromatiques à 5 chaînons substitués par l'indazole
US5317103A (en) * 1991-01-15 1994-05-31 Merck Sharp & Dohme Limited Indole-substituted five-membered heteroaromatic compounds as 5-HT1 agonists
CZ283018B6 (cs) * 1991-02-01 1997-12-17 Merck Sharp And Dohme Limited Deriváty imidazolu, triazolu a tetrazolu a farmaceutické přípravky na jejich bázi
TW263508B (fr) * 1991-02-12 1995-11-21 Pfizer
GB9104136D0 (en) * 1991-02-27 1991-04-17 Merck Sharp & Dohme Therapeutic agents
KR0184911B1 (ko) * 1991-11-25 1999-05-01 알렌 제이. 스피겔 인돌유도체
EP0545478A1 (fr) * 1991-12-03 1993-06-09 MERCK SHARP & DOHME LTD. Composés hétérocycliques comme tachykinine antagonistes
US5409941A (en) * 1992-02-03 1995-04-25 Pfizer Inc. 5-heteroyl indole derivatives
TW288010B (fr) * 1992-03-05 1996-10-11 Pfizer
EP0630374B1 (fr) * 1992-03-13 2001-09-05 MERCK SHARP & DOHME LTD. Derives d'imidazole, de triazole et de tetrazole
GB9207396D0 (en) * 1992-04-03 1992-05-13 Merck Sharp & Dohme Therapeutic agents
JP2644088B2 (ja) 1992-04-07 1997-08-25 フアイザー・インコーポレイテツド 5−ht1作動薬としてのインドール誘導体
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
GB9207930D0 (en) * 1992-04-10 1992-05-27 Pfizer Ltd Indoles
NZ251047A (en) * 1992-04-10 1996-09-25 Pfizer Acylaminoindole derivatives and medicaments
GB9208463D0 (en) * 1992-04-16 1992-06-03 Merck Sharp & Dohme Therapeutic agents
GB9210400D0 (en) * 1992-05-15 1992-07-01 Merck Sharp & Dohme Therapeutic agents
GB9211277D0 (en) 1992-05-28 1992-07-15 Glaxo Group Inc Pharmaceutical compositions
HUT71403A (en) * 1992-06-05 1995-11-28 Merck Sharp & Dohme The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy
GB9215526D0 (en) * 1992-07-22 1992-09-02 Merck Sharp & Dohme Chemical process
AU672802B2 (en) * 1992-07-24 1996-10-17 Merck Sharp & Dohme Limited Imidazole, triazole and tetrazole derivatives
IL106445A (en) * 1992-07-30 1998-01-04 Merck Sharp & Dohme History of 1,2,4-Trans-Triazole 4-Transform, Preparation and Pharmaceutical Preparations Containing Them
TW251284B (fr) * 1992-11-02 1995-07-11 Pfizer
GB9226537D0 (en) * 1992-12-21 1993-02-17 Smithkline Beecham Plc Compounds
LT3594B (en) 1993-07-29 1995-12-27 Merck Sharp & Dohme Imidazole,triazole and tetrazole derivatives
ES2070087B1 (es) * 1993-08-13 1996-02-16 Pfizer Derivados de indol
US6423731B2 (en) 1994-01-06 2002-07-23 Zeneca Limited Indole derivatives as prodrugs of 5-HT1-like receptor agonists
GB9401436D0 (en) * 1994-01-26 1994-03-23 Wellcome Found Therapeutic heterocyclic compounds
GB9407447D0 (en) * 1994-04-14 1994-06-08 Glaxo Group Ltd Chemical compounds
AU2621995A (en) * 1994-06-01 1995-12-21 Zeneca Limited Indole derivatives as prodrugs of 5-ht1-like receptor agonists
WO1996003400A1 (fr) * 1994-07-26 1996-02-08 Pfizer Inc. Derives 4-indole utilises comme agonistes et antagonistes de la serotonine
EP0796258A1 (fr) * 1994-12-06 1997-09-24 MERCK SHARP & DOHME LTD. Derives de l'azetidine, de la pyrrolidine et de la piperidine utilises comme agonistes des recepteurs 5-ht1
GB9516143D0 (en) 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US6909005B1 (en) 1995-08-07 2005-06-21 Astrazeneca Uk Limited One post synthesis of 2-oxazolidinone derivatives
GB9516145D0 (en) * 1995-08-07 1995-10-04 Wellcome Found Improved chemical synthesis
US5998438A (en) * 1996-11-26 1999-12-07 Allelix Biopharmaceuticals, Inc. 5-cyclo indole compounds
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
WO2000000490A2 (fr) * 1998-06-26 2000-01-06 Eli Lilly And Company Agonistes de 5-ht¿1f?
AU2003249582B2 (en) 2002-06-21 2006-08-03 Suven Life Sciences Limited Tetracyclic arylsulfonyl indoles having serotonin receptor affinity
BR0312175A (pt) 2002-06-21 2005-04-05 Suven Life Sciences Ltd Composto, composição farmacêutica, uso de um composto, método para o tratamento e método para reduzir a morbidez e a mortalidade associadas com o excesso de peso
KR100776118B1 (ko) 2002-11-28 2007-11-15 수벤 라이프 사이언시스 리미티드 엔-아릴술포닐-3-아미노알콕시인돌
ES2310243T3 (es) 2002-11-28 2009-01-01 Suven Life Sciences Limited Indoles n-aril-3-sulfonil sustituidos que tienen afinidad por receptores de serotonina, proceso para su preparacion y composicion farmaceutica que los contiene.
JP4571507B2 (ja) 2002-12-18 2010-10-27 スベン ライフ サイエンシズ リミティド セロトニン受容体親和性を有する四環系3−置換インドール
DE102005018191A1 (de) * 2005-04-19 2006-10-26 Grünenthal GmbH Substituierte zyklische Harnstoff-Derivate und deren Verwendung zur Herstellung von Arzneimitteln
EP3407869A1 (fr) 2016-01-27 2018-12-05 Instar Technologies A.S. Supports nanofibreux oromumuqueux pour traitement thérapeutique
CN112759550A (zh) * 2019-11-04 2021-05-07 上海科技大学 一种平滑受体拮抗剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4833153A (en) 1985-11-08 1989-05-23 Glaxo Group Limited Indole derivatives
GB8600397D0 (en) 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
DK586588A (da) 1989-04-24
CN1035113A (zh) 1989-08-30
ATE90089T1 (de) 1993-06-15
DD283140A5 (de) 1990-10-03
FI884879A0 (fi) 1988-10-21
ZA887900B (en) 1990-06-27
AU604165B2 (en) 1990-12-06
PL275423A1 (en) 1989-08-07
DK586588D0 (da) 1988-10-21
PL158305B1 (en) 1992-08-31
AU2418188A (en) 1989-04-27
HUT50163A (en) 1989-12-28
EP0313397B1 (fr) 1993-06-02
DE3881472T2 (de) 1993-12-16
PT88829B (pt) 1993-01-29
EP0313397A1 (fr) 1989-04-26
IL88122A0 (en) 1989-06-30
JP2501631B2 (ja) 1996-05-29
HU202230B (en) 1991-02-28
GB8724912D0 (en) 1987-11-25
DE3881472D1 (de) 1993-07-08
ES2054825T3 (es) 1994-08-16
NZ226671A (en) 1991-09-25
JPH01146882A (ja) 1989-06-08
MC1983A1 (fr) 1989-11-23

Similar Documents

Publication Publication Date Title
FI884879A0 (fi) Terapeutiskt anvaendbara heterocykliska foereningar.
NL300034I2 (nl) Gesubstitueerde thiahzolidinedionderivaten.
FI950016A (fi) Heterosykliset yhdisteet lääkeaineena
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE50987T1 (de) Dihydropyridinderivate, deren herstellung und verwendung.
EP0100189A3 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
NO163855C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylcyklobutylalkylaminer.
DE68917772D1 (de) 2-Alkyl-3-benzoylbenzofurane und diese enthaltende pharmazeutische Zusammensetzungen.
FI853233A0 (fi) 1,6-naftyridinderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska produkter.
DE3787844D1 (de) Thioester und dessen Verwendung zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von Ischämie und von Reperfusion-Syndromen.
AU597923B2 (en) 5-aminoalkyl-beta-carboline derivatives, their production and their use as drugs
NO165593C (no) Analogifremgangsmaate ved fremstilling av nye tetracykliske indolderivater.
ATE160567T1 (de) Psoralen-derivate, deren herstellung und verwendung als arzneimittel
TH11701EX (th) สารประกอบเฮเทโรไซคลิคที่ใช้ในการรักษาโรค

Legal Events

Date Code Title Description
FA Application withdrawn

Owner name: THE WELLCOME FOUNDATION LIMITED